Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban, or Aspirin Plus REGN9933, or Aspirin Plus REGN7508 in Healthy Adult Participants

NCT06444178 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Aspirin
DRUG: REGN9933
DRUG: REGN7508
DRUG: Rivaroxaban

Sponsor

Regeneron Pharmaceuticals